Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatitis B virus (HBV) virion, also known as the Dane particle, is an enveloped 42 nm particle composed of a lipid envelope with embedded hepatitis B surface antigens (HBsAg) and an icosahedral nucleocapsid core made of hepatitis B core antigen (HBcAg), which contains the partially double-stranded, relaxed-circular viral DNA and a reverse transcriptase/DNA polymerase protein. The virion’s function is to mediate viral entry into hepatocytes, deliver its genome, and initiate infection. Key antigenic components include HBsAg, HBcAg, HBeAg, and accessory regulatory proteins (e.g., HBx). While the virion itself is not a direct therapeutic target, its components (polymerase, core protein, envelope proteins) serve as molecular targets for antiviral drugs and immune therapies[1][2][4][5][6]
Inhibition of viral reverse transcriptase/DNA polymerase Inhibition of viral entry (e.g., NTCP receptor blocking) Immune modulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B virus virion.